10月29日，步长制药（证券代码：603858）公告，公司的控股子公司泸州步长与越南公司Helios Pharmaceutical Company Limited及早安国际贸易有限公司签署了《经销、营销服务和代理协议》。根据协议，泸州步长授权Helios在越南区域内独家营销和经销注射用Efparepoetin alfa（注射用依派促红素a），该药品适用于治疗成人透析患者因慢性肾脏病引起的贫血，目前 ...

BRIDGEWATER – Gov. Phil Murphy attended the opening of corporate offices for an international pharmaceutical company in the ...

Aging populations and clearer U.S. drug pricing boost long-term pharma outlook. Leaders like Eli Lilly and Merck lead in ...

AI and accelerated computing are transforming the bio/pharmaceutical sector by addressing organizational, technological, and ...

Key Points Added 4,306,363 Teva shares, an estimated $75.64 million trade based on the average quarterly price for Q3 2025 Transaction represents a 0.68% increase in reportable U.S. equity assets ...

CPHI Pharma Awards 2025 recognized innovations in bio/pharmaceutical development, emphasizing sustainability, drug delivery, ...

Ultragenyx Pharmaceutical (RARE) shares have seen some movement lately, attracting attention from investors curious about the company’s direction. The stock has delivered a 21% gain over the past ...

BioMarin Pharmaceutical ( BMRN +1.56%) reported its third-quarter earnings after market close Monday, and they were good enough to push the biotech stock almost 2% higher the following day. With that ...

Application based on positive results from Phase 3 PEGASUS study, which demonstrated statistically significant blood phenylalanine (Phe) lowering compared to diet ...

The company crushed analyst profitability estimates, both for its trailing quarter and for its full-year guidance.